Dayang reported its 2QFY21 results with a headline net loss of RM21.9m, attributed to impairment loss on assets amounting to RM27.9m. Stripping this out, Dayang reported a core net profit of RM6m, improving from the RM1.3m core net loss reported in 2QFY20. Cumulatively, it reported a core net loss of RM18.3m for 1HFY21, against RM12.4m core net profit in 1HFY20. The numbers are below our and consensus expectations of a full year profit of RM85.5m and RM81.1m respectively. The weaker performance was attributed to lower efficiency levels due to movement restrictions and stricter SOPs implemented, as well as unexpected events occurring during the period, resulting in gross profit margin compressing by 19ppt YTD. Given the still-high COVID-19 infections and fatality rates, we foresee the level of productivity remaining low, affecting the overall performance for this year. As such, we lower our FY21 forecast by 81.9% while FY22-23F is cut by 21% on average to reflect slower progress billings and profit margins. Earnings from FY22 onwards will improve however, on the back of a healthy orderbook of RM2.3bn as well as improved efficiencies given the gradual relaxation on SOPs post COVID-19 vaccination. Maintain Outperform with TP revised to RM1.35 (from RM1.77 previously) based on 14x PER multiple over FY22 EPS of 9.68sen.
Source: PublicInvest Research - 21 Sept 2021
Chart | Stock Name | Last | Change | Volume |
---|